Urgent.News

What's breaking now, across thousands of outlets.

Editions

World

To outcompete China, unhandcuff America’s biotech innovators

Former official David Mansdoerfer argues that bureaucratic delays at the FDA threaten American leadership in the growing regenerative medicine sector and give international competitors like China a strategic advantage.

To outcompete China, unhandcuff America’s biotech innovators

We haven't written up this one. The Hill has the full story — the link below goes straight to it.

Read the original at thehill.com →

More in World

More from Thursday 20 August →